Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Phase I dose escalation study of MS-325 complete

March 24, 1998

FDA approves first ultrasound device for early diagnosis of osteoporosis

March 23, 1998

ZymeTx's ZStatFlu shows efficacy for detection of Hong Kong flu virus

March 23, 1998

CEA-Scan to be distributed by Bergen Brunswig in U.S.

March 20, 1998

Daiichi to market Nycomed Amersham's ultrasound contrast agent in Japan

March 20, 1998

FDA clears free PSA blood test

March 19, 1998

EchoGen up for discussion by CPMP and FDA advisory committee

March 18, 1998

MRX-115 allows for accurate assessment of AMI in dogs

March 17, 1998

Thymus-specific chemokine protein disclosed by HGS

March 16, 1998

Genzyme General: Q4 1997 highlights

March 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...